Clinical Trial Update: Echinacea Safety Study [Phase 4]

View source ↗

Summary

A Phase 4 safety study of echinacea conducted by A. Vogel AG has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infectious Diseases

Drugs mentioned

• Echinacea (Echinacea)

Snippet

Sponsor: A. Vogel AG | Conditions: Infections | Phase 4 | Status: COMPLETED